<DOC>
	<DOCNO>NCT02969239</DOCNO>
	<brief_summary>The purpose study compare norepinephrine phenylephrine effect maintain cardiac output Cesarean section spinal anesthesia .</brief_summary>
	<brief_title>Norepinephrine Phenylephrine Maternal Cardiac Output During Spinal Anesthesia Elective Cesarean Delivery</brief_title>
	<detailed_description>CO measure use NICOMÂ® monitor . Bioreactance , development impedance technology , also emerge accessible mode continuous CO monitoring operating room provide valuable insight hemodynamic effect intervention . This method monitoring provide continuous CO , stroke volume ( SV ) heart rate ( HR ) monitoring , intermittent BP SVR assessments 1-minute interval . Either phenylephrine ( 100 mcg/ml ) norepinephrine ( 0.5 mcg/ml ) 50-ml syringe label `` study drug '' . She involve patient 's care study assessment . The hypotension define systolic blood pressure &lt; 80 % baseline &lt; 90 mmHg , manage study drug ( 1 ml ) intravenously . The bradycardia define HR &lt; 60 beats/min record manage atropine ( 0.5 mg ) intravenously HR &lt; 45 beats/min . The presence nausea vomit measure 3 point scale ( 1 = nausea vomiting , 2 = nausea , 3 = nausea vomit ) manage ondansetron ( 4mg ) intravenously .</detailed_description>
	<mesh_term>Hypotension</mesh_term>
	<mesh_term>Phenylephrine</mesh_term>
	<mesh_term>Oxymetazoline</mesh_term>
	<mesh_term>Norepinephrine</mesh_term>
	<mesh_term>Vasoconstrictor Agents</mesh_term>
	<criteria>ASA class I II , term pregnancy ( gestational age &gt; 37weeks ) , plan spinal anesthesia elective cesarean section preexist gestational hypertension , cerebrovascular cardiovascular disease , contraindication spinal anesthesia , fetal anormaly , weight &lt; 50kg &gt; 100kg , height &lt; 140cm &gt; 180cm .</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>